LAM Group’s AbbVie ABBV Stock Holding History

LAM Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.6K	Hold	293	–	–	0.04%	87
2026 Q1	$63.6K	Buy	+293	New	+$65K	0.04%	85

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LAM Group's ABBV Position: Q2 2026 in Review

LAM Group held its AbbVie (ABBV) position steady in Q2 2026 at 293 shares worth $73.6K. The position accounts for 0.04% of the portfolio, ranked #87.

LAM Group first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 2,070 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LAM Group held 293 shares of AbbVie worth $73.6K as of Q2 2026.
LAM Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of LAM Group's portfolio in Q2 2026, its #87 holding.
LAM Group first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
2,070 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LAM Group's 13F filing for Q2 2026, filed 10 Jul 2026.